BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 12, 2011
View Archived Issues
Lipoxen provides update on pipeline and other activities
Read More
Researchers present structure and new pharmacological data on AZD-9668
Read More
Sanofi patents novel tryptase beta inhibitors
Read More
Ono Pharmaceutical reviews activities of first quarter of fiscal year 2011
Read More
Polish health authorities clear phase IIa trial of oral CD3-targeted immunotherapy in hepatitis C
Read More
Hybrigenics presents new inhibitors of ubiquitin carboxyl-terminal hydrolase 7
Read More
FDA approves second single-pill complete antiretroviral therapy for untreated HIV-1 infection
Read More
Merck & Co. prepares new HCV NS5B inhibitors
Read More
Biogen Idec and Abbott report on phase II registrational study of DAC HYP
Read More
FDA assigns PDUFA date for Affymax's peginesatide NDA
Read More
Roche synthesizes new JAK1 inhibitors
Read More
Nereus Pharmaceuticals presents novel dehydrophenylahistins for cancer
Read More
New molecules for diabetic foot ulcers prepared
Read More
Topline data reported from two phase II studies of ADL-5945
Read More
Genesis Biopharma signs agreement to develop cancer immunotherapies
Read More
Tuberculosis vaccine enters phase IIb trial in HIV-infected adults
Read More
FDA sets new PDUFA action date for Bydureon
Read More
Neoprobe submits NDA for Lymphoseek
Read More
Isis Pharmaceuticals and CHDI Foundation renew collaboration for Huntington's disease
Read More
Jennerex raises funds to support JX-594 development
Read More
Amorfix provides update on preclinical development of anticancer therapeutic antibodies
Read More
MediciNova enters collaboration for phase II trial of ibudilast in headache disorder
Read More
Yaupon raises funds to support review process of mycosis fungoides therapy
Read More